Cdc42(G12V) has been implicated as a driver mutation in melanoma necessary for invasion of melanoma cells [21,22] Furthermore, increased Cdc42 expression has been associated with a poorer prognosis and its effectors are associated with increased resistance to BRAF inhibitors [23,24]. Here, BRAF is linked to melanoma.